Jin Medical International Ltd. (ZJYL) stock
Close on Nov 17, 2026Market cap $528.35MP/E 16.9Yield –
Jin Medical International Ltd. saw revenue fall 12.0% to $20.69M over fiscal 2025. Operating income fell 83.3% to $608.18K, moving the operating margin from 15.5% to 2.9%. Free cash flow was -$3.73M. At the latest close the market valued the company at $528.35M, 16.9 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Mar 31, 2026
Valuation
- Market cap
- $528.35M
- P/E ratio
- 16.9
- Price to sales
- 25.54
- Price to book
- 17.43
- Dividend yield
- –
- Free cash flow yield
- -0.71%
Fundamentals
- Revenue
- $20.69M
- Net income
- $1.19M
- EPS, diluted
- $0.20
- Free cash flow
- -$3.73M
Trading
- Previous close
- $3.63
- Open
- $3.62
- Day's range
- $3.21 – $3.62
- Volume
- 27,878
- Average volume (20 days)
- 246,621
- 52-week range
- $1.53 – $5.68
- RSI (14 days)
- 55.8
- Volatility (1 year)
- 113.3%
- Relative volume
- 0.05×
Market cap history
Month-end market cap since 2023, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 17, 2026. The S&P 500 is measured by the SPY fund.
| Period | ZJYL | S&P 500 | Difference | ZJYL per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +62.3% | -4.0% | +66.3 pts | ||
| 3 months | -2.5% | -5.0% | +2.5 pts | ||
| Year to date | -23.3% | +8.2% | −31.5 pts | ||
| 1 year | -39.6% | +11.2% | −50.8 pts | ||
| 3 years | -73.3% | +68.5% | −141.7 pts | -35.6% | +19.0% |
Six years at a glance
Fiscal years 2020 to 2025, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Jin Medical International filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About Jin Medical International
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Jin Medical International Ltd. is a holding company that develops and manufactures medical and technology products through its operating entities in the People's Republic of China. The company produces equipment and components across dedicated production facilities, while also expanding into newer product categories. It supplies these products through an established commercial network composed of independent distributors and dealers, serving commercial clients as well as a major primary customer that accounts for a significant portion of its sales volume.
Company profile, executives and historyJin Medical International stock: common questions
What is Jin Medical International's stock price?
ZJYL closed at $3.38 on Nov 17, 2026, down 7.02% on the day. Over the past 52 weeks it traded between $1.53 and $5.68.
What is Jin Medical International's market cap?
Jin Medical International was worth $528.35M at the close on Nov 17, 2026: the share price times the diluted shares outstanding.
What is ZJYL's P/E ratio?
ZJYL trades at 16.9 times earnings, based on diluted earnings per share of $0.20 over fiscal 2025.
How much revenue does Jin Medical International make?
Jin Medical International reported revenue of $20.69M for fiscal 2025, down 12.0% from a year earlier.
Does Jin Medical International pay a dividend?
No. Jin Medical International has not paid a cash dividend over the last twelve months.
How has ZJYL stock performed over the past year?
Including dividends, ZJYL returned -39.6% over the past year, against +11.2% for the S&P 500.
How many ZJYL shares are sold short?
0M shares were sold short at the latest FINRA report, 0.01% of the float, or 1.0 days of average trading volume.
Who are Jin Medical International's competitors?
Companies most similar to Jin Medical International by business, industry and size include WOK, BDMD, LFWD, MHUAF, MLSS.
See a number that looks wrong?